Mefcom Capital (531176)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Positive book value per share of ₹6.24 provides some asset backing
• Latest quarter sales of ₹26 Cr show the business still has operating scale relative to a ₹68 Cr market cap
• Small market cap leaves room for outsized per-share gains if operations are genuinely turned around
• The stock trades well above its 52-week low of ₹8.50, indicating some market interest

Concerns

• Negative ROE of -4.41% and ROCE of -7.74% show the company is destroying shareholder value
• Sales are down 36.05% and profit down 25.25%, with the latest quarter showing a ₹1 Cr net loss
• Piotroski F-Score of 2/9 points to weak financial health
• At ₹14.95 against book value of ₹6.24, P/B of 2.40 offers no Graham-style margin of safety

AI Analysis

When I look at Mefcom Capital, the first thing I notice is that it earns nothing. Return on equity is -4.41%, and return on capital employed is -7.74%. A business that earns negative returns on capital is a value destroyer, no matter what its market cap is. Sales have fallen 36%, profits have fallen 25%, and the latest quarter shows ₹26 crore of sales but a ₹1 crore loss. There is no earnings stream to put a P/E multiple on, so the P/E of 0.00 is not cheap; it is simply the absence of value. The price of ₹14.95 is 2.4 times book value of ₹6.24. Benjamin Graham taught me to buy assets at a discount, not at a premium, especially when those assets are earning a negative return. The Piotroski F-score of 2 out of 9 reinforces my suspicion: the financial health is poor. There is no dividend to compensate me while I wait. The one positive is that the company still generates meaningful quarterly sales of ₹26 crore, so it is not an empty shell. But at this size, with this decline, that is not a moat. Capital market services is a competitive, cyclical field, and this business shows no durable competitive advantage. I cannot evaluate promoter holding because it is not disclosed, and that makes me more cautious. Would I buy the whole company for ₹68 crore? Not today. For a margin of safety, I would need a much lower price, positive earnings, or clear evidence of a turnaround. Until then, this is a pass. As Buffett says, you can't make a good deal with a bad business. Mefcom may one day revive, but I will wait for proof rather than speculate on hope.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer